Skip to Main content Skip to Navigation
Theses

Estimation du bénéfice de survie à partir de méta-analyse sur données individuelles et évaluation économique.

Abstract : The survival benefit restricted up to a certain time horizon has been suggested as an alternative measure to the common relative measures used to estimate the treatment effect, especially in case of non-proportional hazards of death. The restricted survival benefit corresponds to the difference of the two restricted mean survival times estimated for each treatment arm, and is expressed in terms of life years gained. In the literature, this measure is considered as more intuitive than the hazard ratio and many authors have suggested its use for the design and the analysis of clinical trials. However, it is not currently the most used measure in randomized trials. This measure is valid under any distribution of the survival times and is adapted if the proportional hazards assumption does not hold. In addition, the restricted survival benefit can be used in medico-economic evaluation where an absolute measure of the treatment effect is needed (number of [quality adjusted] life years gained). If one wants to estimate the restricted survival benefit from an individual participant data meta-analysis, there is a need to take into account the trial effect due to the hierarchical structure of the data. The aim of this thesis was to compare statistical methods to estimate the restricted survival benefit from an individual participant data meta-analysis of randomized trials. The starting point was a case study (cost-effectiveness analysis) using data from the Meta-Analysis of Radiotherapy in Lung Cancer. This study showed that the five investigated methods yielded different estimates for the restricted survival benefit and its confidence interval. The choice of a method to estimate the survival benefit also impacted on cost-effectiveness results. Our second project consisted in a simulation study to have a better understanding of the properties of the investigated methods in terms of bias and standard error. Finally, the last part of the thesis illustrated the lessons learned from the simulation study through three examples of individual participant data meta-analysis in nasopharynx cancer and in small cell lung cancer.
Document type :
Theses
Complete list of metadata

Cited literature [149 references]  Display  Hide  Download

https://tel.archives-ouvertes.fr/tel-01396362
Contributor : Abes Star :  Contact
Submitted on : Monday, November 14, 2016 - 1:10:08 PM
Last modification on : Sunday, February 2, 2020 - 10:18:34 PM

File

73972_LUEZA_2016_diffusion.pdf
Version validated by the jury (STAR)

Identifiers

  • HAL Id : tel-01396362, version 1

Collections

Citation

Béranger Lueza. Estimation du bénéfice de survie à partir de méta-analyse sur données individuelles et évaluation économique.. Santé publique et épidémiologie. Université Paris-Saclay, 2016. Français. ⟨NNT : 2016SACLS268⟩. ⟨tel-01396362⟩

Share

Metrics

Les métriques sont temporairement indisponibles